• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接触系统在脓毒症休克中的作用:下一个靶点?当前证据概述。

The role of contact system in septic shock: the next target? An overview of the current evidence.

作者信息

Nicola Henrique

机构信息

Intensive Care Registrar Trainee, Royal Perth Hospital, 197 Wellington St Perth, Western Australia, 6000 Australia.

出版信息

J Intensive Care. 2017 May 30;5:31. doi: 10.1186/s40560-017-0228-x. eCollection 2017.

DOI:10.1186/s40560-017-0228-x
PMID:28572980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5450093/
Abstract

BACKGROUND

Septic shock remains challenging to intensive care units worldwide, despite recent documented improvement in mortality over the years. Multiple new therapies have been attempted without success in large clinical trials. Evidence concerning the role of the contact system and bradykinin on septic shock physiological manifestations is shown by this article.

OBJECTIVES

The objective of the study is to review the current evidence linking contact system activation and septic shock, as well as efficacy of available therapies targeting this pathophysiological pathway and to evaluate the potential of further researching the matter.

RESULTS

Multiple animal studies are already available and suggestive of a meaningful role of contact system activation on septic shock. However, human trials are still scarce, and the ones available are not enough to establish such a strong connection. Furthermore, attempted therapies have been successful across multiple species, but not as much in humans. Therefore, contact system and septic shock relationship remains plentiful in questions to be answered in the coming years or decades.

CONCLUSIONS

Whether the contact system is not as relevant in humans as it is in animals or there is only lack of evidence remains to be explained. The subject is an attractive open field for further research aiming to aid in tackling such a burdensome condition.

摘要

背景

尽管近年来有文献记载脓毒症休克的死亡率有所改善,但它仍然是全球重症监护病房面临的挑战。多种新疗法在大型临床试验中尝试但未成功。本文展示了关于接触系统和缓激肽在脓毒症休克生理表现中作用的证据。

目的

本研究的目的是回顾当前将接触系统激活与脓毒症休克联系起来的证据,以及针对这一病理生理途径的现有疗法的疗效,并评估进一步研究该问题的潜力。

结果

已有多项动物研究表明接触系统激活在脓毒症休克中具有重要作用。然而,人体试验仍然很少,现有的人体试验不足以建立如此紧密的联系。此外,尝试的疗法在多个物种中取得了成功,但在人体中效果不佳。因此,接触系统与脓毒症休克的关系在未来几年或几十年仍有许多问题有待解答。

结论

接触系统在人类中是否不如在动物中相关,或者只是缺乏证据,仍有待解释。该主题是一个有吸引力的开放研究领域,旨在帮助应对这种棘手的病症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c612/5450093/10a5afd75243/40560_2017_228_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c612/5450093/10a5afd75243/40560_2017_228_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c612/5450093/10a5afd75243/40560_2017_228_Fig1_HTML.jpg

相似文献

1
The role of contact system in septic shock: the next target? An overview of the current evidence.接触系统在脓毒症休克中的作用:下一个靶点?当前证据概述。
J Intensive Care. 2017 May 30;5:31. doi: 10.1186/s40560-017-0228-x. eCollection 2017.
2
Sepsis Care Pathway 2019.2019年脓毒症护理路径
Qatar Med J. 2019 Nov 7;2019(2):4. doi: 10.5339/qmj.2019.qccc.4. eCollection 2019.
3
The controversial role of corticosteroids in septic shock.皮质类固醇在感染性休克中的争议性作用。
Am J Emerg Med. 2019 Jul;37(7):1353-1361. doi: 10.1016/j.ajem.2019.04.045. Epub 2019 Apr 26.
4
Mortality rates in pediatric septic shock with and without multiple organ system failure.伴有和不伴有多器官系统衰竭的小儿感染性休克的死亡率。
Pediatr Crit Care Med. 2003 Jul;4(3):333-7. doi: 10.1097/01.PCC.0000074266.10576.9B.
5
Incidence and mortality of severe sepsis in surgical intensive care patients: the influence of patient gender on disease process and outcome.外科重症监护患者严重脓毒症的发病率和死亡率:患者性别对疾病进程及结局的影响
Intensive Care Med. 2000 Feb;26(2):167-72. doi: 10.1007/s001340050041.
6
Contributions of a survey and retrospective cohort study to the planning of a randomised controlled trial of corticosteroids in the treatment of paediatric septic shock.一项调查和回顾性队列研究对皮质类固醇治疗小儿脓毒性休克随机对照试验规划的贡献。
Trials. 2018 May 21;19(1):283. doi: 10.1186/s13063-018-2664-x.
7
Antithrombin replacement in patients with sepsis and septic shock.脓毒症和脓毒性休克患者的抗凝血酶替代治疗
Haematologica. 1999 May;84(5):452-60.
8
Effect of norepinephrine on the outcome of septic shock.去甲肾上腺素对感染性休克结局的影响。
Crit Care Med. 2000 Aug;28(8):2758-65. doi: 10.1097/00003246-200008000-00012.
9
Clinical management for patients admitted to a critical care unit with severe sepsis or septic shock.重症监护病房收治的严重脓毒症或脓毒性休克患者的临床管理。
Intensive Crit Care Nurs. 2015 Dec;31(6):359-65. doi: 10.1016/j.iccn.2015.04.005. Epub 2015 Aug 17.
10
Benefits and harms of red blood cell transfusions in patients with septic shock in the intensive care unit.重症监护病房中感染性休克患者红细胞输血的益处与危害
Dan Med J. 2016 Feb;63(2).

引用本文的文献

1
Hereditary Angioedema With a Normal Complement Level.补体水平正常的遗传性血管性水肿
Cureus. 2024 Jan 15;16(1):e52291. doi: 10.7759/cureus.52291. eCollection 2024 Jan.
2
Anti-HK antibody inhibits the plasma contact system by blocking prekallikrein and factor XI activation in vivo.抗-HK 抗体通过阻断血浆接触系统中激肽原和因子 XI 的激活来抑制体内的血浆接触系统。
Blood Adv. 2023 Apr 11;7(7):1156-1167. doi: 10.1182/bloodadvances.2021006485.
3
Mass spectrometric study of variation in kinin peptide profiles in nasal fluids and plasma of adult healthy individuals.

本文引用的文献

1
Levosimendan for the Prevention of Acute Organ Dysfunction in Sepsis.左西孟旦用于预防脓毒症急性器官功能障碍
N Engl J Med. 2016 Oct 27;375(17):1638-1648. doi: 10.1056/NEJMoa1609409. Epub 2016 Oct 5.
2
New insights into the stereochemical requirements of the bradykinin B1 receptor antagonists binding.对缓激肽B1受体拮抗剂结合的立体化学要求的新见解。
J Mol Graph Model. 2016 Jul;68:184-196. doi: 10.1016/j.jmgm.2016.06.010. Epub 2016 Jul 1.
3
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
成年健康个体鼻分泌物和血浆中激肽肽谱变化的质谱研究。
J Transl Med. 2022 Mar 29;20(1):146. doi: 10.1186/s12967-022-03332-8.
4
Anti-HK antibody reveals critical roles of a 20-residue HK region for Aβ-induced plasma contact system activation.抗 HK 抗体揭示了 20 残基 HK 区域对 Aβ诱导的血浆接触系统激活的关键作用。
Blood Adv. 2022 May 24;6(10):3090-3101. doi: 10.1182/bloodadvances.2021006612.
5
Reliable measurement of plasma kinin peptides: Importance of preanalytical variables.血浆激肽肽的可靠测量:分析前变量的重要性。
Res Pract Thromb Haemost. 2022 Jan 12;6(1):e12646. doi: 10.1002/rth2.12646. eCollection 2022 Jan.
6
Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity.代谢相关脂肪性肝病中先天性和适应性免疫的改变及其对COVID-19严重程度的影响。
Front Immunol. 2021 Mar 30;12:651728. doi: 10.3389/fimmu.2021.651728. eCollection 2021.
7
Targeted LC-MS/MS platform for the comprehensive determination of peptides in the kallikrein-kinin system.靶向 LC-MS/MS 平台用于 Kallikrein-Kinin 系统中肽的全面测定。
Anal Bioanal Chem. 2021 May;413(11):2971-2984. doi: 10.1007/s00216-021-03231-9. Epub 2021 Mar 10.
8
The contact system proteases play disparate roles in streptococcal sepsis.接触系统蛋白酶在链球菌脓毒症中发挥不同的作用。
Haematologica. 2020 May;105(5):1424-1435. doi: 10.3324/haematol.2019.223545. Epub 2019 Jul 18.
9
Bradykinin receptor deficiency or antagonism do not impact the host response during gram-negative pneumonia-derived sepsis.缓激肽受体缺乏或拮抗不影响革兰氏阴性菌肺炎所致脓毒症期间的宿主反应。
Intensive Care Med Exp. 2019 Mar 12;7(1):14. doi: 10.1186/s40635-019-0228-3.
10
Interaction of the Human Contact System with Pathogens-An Update.人类接触系统与病原体的相互作用——最新进展。
Front Immunol. 2018 Feb 26;9:312. doi: 10.3389/fimmu.2018.00312. eCollection 2018.
《脓毒症及脓毒性休克第三次国际共识定义(脓毒症-3)》
JAMA. 2016 Feb 23;315(8):801-10. doi: 10.1001/jama.2016.0287.
4
Kinin B1 Receptor Inhibition With BI113823 Reduces Inflammatory Response, Mitigates Organ Injury, and Improves Survival Among Rats With Severe Sepsis.缓激肽 B1 受体抑制药 BI113823 可减轻严重脓毒症大鼠的炎症反应,减轻器官损伤,提高生存率。
J Infect Dis. 2016 Feb 15;213(4):532-40. doi: 10.1093/infdis/jiv426. Epub 2015 Aug 26.
5
Contact pathway of coagulation and inflammation.凝血和炎症的接触途径。
Thromb J. 2015 May 6;13:17. doi: 10.1186/s12959-015-0048-y. eCollection 2015.
6
Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000-2012.2000-2012 年澳大利亚和新西兰重症监护病房严重脓毒症和脓毒性休克患者的死亡率。
JAMA. 2014 Apr 2;311(13):1308-16. doi: 10.1001/jama.2014.2637.
7
Drotrecogin alfa (activated) in adults with septic shock.活化的人重组凝血因子 VII 治疗成人感染性休克。
N Engl J Med. 2012 May 31;366(22):2055-64. doi: 10.1056/NEJMoa1202290. Epub 2012 May 22.
8
The role of bradykinin and the effect of the bradykinin receptor antagonist icatibant in porcine sepsis.缓激肽的作用和缓激肽受体拮抗剂依替巴肽在猪脓毒症中的作用。
Shock. 2011 Nov;36(5):517-23. doi: 10.1097/SHK.0b013e3182336a34.
9
Intestinal tissue kallikrein-kinin system in inflammatory bowel disease.炎症性肠病中的肠组织激肽释放酶-激肽系统。
Inflamm Bowel Dis. 2011 Feb;17(2):645-54. doi: 10.1002/ibd.21337.
10
Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema.纳米过滤的 C1 抑制剂浓缩物用于遗传性血管性水肿的治疗。
N Engl J Med. 2010 Aug 5;363(6):513-22. doi: 10.1056/NEJMoa0805538.